KKR Real Estate Finance Trust Inc. (NYSE:KREF) held its 2026 Annual Meeting, re-electing all eight directors and ratifying Deloitte & Touche LLP as its independent auditor. Shareholders also approved the advisory compensation for named executive officers. The company is currently trading at $6.62 with a 15% dividend yield, though InvestingPro analysis suggests it may be overvalued.

Archer Daniels Midland Company (NYSE:ADM) saw a 17.1% decrease in short interest during March, falling to 13,081,635 shares by March 31st, representing 2.7% of its shares short. The company recently beat quarterly EPS estimates but its revenue fell, and analysts hold a consensus "Hold" rating with an average target price of $63.86. ADM also increased its quarterly dividend to $0.52 per share.

Trinity Industries Inc (TRN) shares dropped 3.0% to $32.47, a price GuruFocus identifies as significantly overvalued compared to its intrinsic GF Value™ of $22.40. Despite a GF Score™ of 69/100, indicating above-average potential, concerns arise from its low financial strength (4/10) and limited growth prospects (2/10). Investors are cautioned due to the substantial premium over its GF Value™.

Amazon Web Services (AWS) has launched Amazon Bio Discovery, an AI-powered drug discovery tool designed to accelerate the early-stage development of antibody therapies. This new agentic AI application provides scientists with access to specialized biological foundation models and allows them to use natural language to design and test novel drugs, aiming to overcome the challenges of integrating complex AI models into research. The platform has already demonstrated significant time savings in antibody design for Memorial Sloan Kettering Cancer Center, reducing a year-long process to just weeks.

Unilever is increasing the price it charges retailers for Hellmann's mayonnaise by 9%, effective in early July, due to a "significant increase" in its costs, particularly rising fuel prices impacting global supply chains. This move reflects a broader trend among suppliers in Canada and globally who are implementing surcharges or price hikes to cover escalating transportation expenses. While some major grocers are pushing back against these increases, smaller independent retailers are expected to bear a disproportionate burden.

Andrew D. Dickinson, CFO of Gilead Sciences, sold 3,000 shares of company stock for a total of $422,880 on April 15, 2026. This transaction was executed under a pre-arranged trading plan, with the stock currently valued at $138.49 and having provided a 36% return over the past year. The company has also raised its dividend for 11 consecutive years and is trading near its Fair Value according to InvestingPro.

Johanna Mercier, Chief Comm & Corp Aff Officer at Gilead Sciences, sold 3,000 shares of common stock for $422,880 on April 15, 2026, under a Rule 10b5-1 trading plan. This transaction leaves Mercier with 128,779 direct shares. The company has also expanded access to its HIV prevention drug, lenacapavir, and enhanced its oncology pipeline through a collaboration with Tempus AI, while analysts have maintained positive ratings and price targets.

Intapp Inc.'s stock surged by 8.9% to $23.05 after its latest earnings report showed better-than-expected revenue. Despite this, analysts have mixed views on the company's future, with price targets ranging from $25 to $54 and ratings from 'Sell' to 'Buy'. The company provides cloud-based software for professional services and its stock volatility reflects ongoing uncertainty about its growth and profitability.

RTX stock fell 1.3% during trading on Thursday, with trading volume significantly below average. Despite recent positive operational developments, such as successful sensor flight tests and new contract wins, the stock faces mixed market signals including analyst price target cuts, an analyst downgrade, and insider selling. Analysts currently hold a "Moderate Buy" consensus on RTX, with a target price of $203.61.

AT&T Inc (T) shares surged 3.7% to $26.40, yet GuruFocus assesses the stock as 22.3% overvalued with a GF Value™ of $21.59, despite a GF Score™ of 74 indicating it's an Above Average stock primarily due to its profitability. The lack of insider transactions in the last three months suggests limited insider confidence, advising caution for investors due to potential downside risk.